In addition, it has been reported that plasma CXCL12 levels were significantly elevated in the blood of patients with TAPS regardless of the arterial/venous nature of the thrombosis compared with HCs (24), which was similar to the results of our study. This evidence concerns the gene CXCL12 and deep vein thrombosis.